Minimed Diabetic Infusion Set
Minimed Diabetic Infusion Set Side Effects May Be Linked To Hospitalization Lawsuits
Minimed Diabetic Infusion Set | Lawsuits, Lawyers | Side Effects: Elevated Blood Sugar, Hospitalization, Serious Injuries, Death | Unintentional Disconnection, Interruption of Insulin
More than 160,000 insulin infusion sets are being recalled because of problems that have caused 200 diabetics to be hospitalized for elevated blood-sugar levels. Medtronic, Inc. today announced that it is recalling all of its Paradigm Quick-set Plus diabetic insulin infusion sets because of problems that can interrupt insulin flow to diabetics who use them. These problems have resulted in a number of serious injuries, including the above mentioned hospitalizations. Medtronic’s recall applies to all Paradigm Quick-Set Plus models (MMT-359S6, MMT-359S9, MMT-359L6 and MMT-359L9) and lot numbers.
Medtronic first warned there were reports of complications arising from the infusion pumps In March 2004. The Paradigm Quick-set Plus infusion sets deliver insulin from an infusion pump to a patient’s body. The complaints involved problems with bending of the infusion set’s cannula or unintentional disconnection of the set at the insertion site. The interruption of insulin flow in diabetics can cause serious problems, including death.
The U.S. Food and Drug Administration (FDA) classified this voluntary action as a Class I recall.
Legal Help For Victims Affected By Minimed Diabetic Infusion Set
If you or a loved one suffered injuries from a Medtronic Diabetic infusion set, please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).